Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group
- 18 March 2015
- journal article
- Published by Springer Science and Business Media LLC in Diabetologia
- Vol. 58 (5), 862-870
- https://doi.org/10.1007/s00125-015-3513-z
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Differences in the Management of Type 1 Diabetes Among Adults Under Excellent Control Compared With Those Under Poor Control in the T1D Exchange Clinic RegistryDiabetes Care, 2013
- Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetesDiabetes & Metabolism, 2013
- Threshold-Based Insulin-Pump Interruption for Reduction of HypoglycemiaThe New England Journal of Medicine, 2013
- Insulin PumpsDiabetes Technology & Therapeutics, 2013
- The T1D Exchange Clinic RegistryJournal of Clinical Endocrinology & Metabolism, 2012
- Insulin Infusion Set: The Achilles Heel of Continuous Subcutaneous Insulin InfusionJournal of Diabetes Science and Technology, 2012
- Factors associated with increased risk of insulin pump discontinuation in pediatric patients with type 1 diabetesPediatric Diabetes, 2010
- Discontinuation of insulin pump treatment in children, adolescents, and young adults. A multicenter analysis based on the DPV database in Germany and AustriaPediatric Diabetes, 2010
- Technical risks with subcutaneous insulin infusionDiabetes & Metabolism, 2006
- Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia.BMJ, 1978